Delirium accelerates cognitive decline in alzheimer disease

T. G. Fong, R. N. Jones, P. Shi, E. R. Marcantonio, L. Yap, J. L. Rudolph, Frances Margaret Yang, D. K. Kiely, S. K. Inouye

Research output: Contribution to journalArticle

236 Citations (Scopus)

Abstract

OBJECTIVE: To examine the impact of delirium on the trajectory of cognitive function in a cohort of patients with Alzheimer disease (AD). METHODS: A secondary analysis of data collected from a large prospective cohort, the Massachusetts Alzheimer's Disease Research Center's patient registry, examined cognitive performance over time in patients who developed (n = 72) or did not develop (n = 336) delirium during the course of their illnesses. Cognitive performance was measured by change in score on the Information-Memory- Concentration (IMC) subtest of the Blessed Dementia Rating Scale. Delirium was identified using a previously validated chart review method. Using linear mixed regression models, rates of cognitive change were calculated, controlling for age, sex, education, comorbid medical diagnoses, family history of dementia, dementia severity score, and duration of symptoms before diagnosis. RESULTS: A significant acceleration in the slope of cognitive decline occurs following an episode of delirium. Among patients who developed delirium, the average decline at baseline for performance on the IMC was 2.5 points per year, but after an episode of delirium there was further decline to an average of 4.9 points per year (p = 0.001). Across groups, the rate of change in IMC score occurred about three times faster in those who had delirium compared to those who did not. CONCLUSIONS: Delirium can accelerate the trajectory of cognitive decline in patients with Alzheimer disease (AD). The information from this study provides the foundation for future randomized intervention studies to determine whether prevention of delirium might ameliorate or delay cognitive decline in patients with AD.

Original languageEnglish (US)
Pages (from-to)1570-1575
Number of pages6
JournalNeurology
Volume72
Issue number18
DOIs
StatePublished - May 5 2009

Fingerprint

Delirium
Alzheimer Disease
Dementia
Medical History Taking
Cognitive Dysfunction
Sex Education
Cognition
Registries
Linear Models

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Fong, T. G., Jones, R. N., Shi, P., Marcantonio, E. R., Yap, L., Rudolph, J. L., ... Inouye, S. K. (2009). Delirium accelerates cognitive decline in alzheimer disease. Neurology, 72(18), 1570-1575. https://doi.org/10.1212/WNL.0b013e3181a4129a

Delirium accelerates cognitive decline in alzheimer disease. / Fong, T. G.; Jones, R. N.; Shi, P.; Marcantonio, E. R.; Yap, L.; Rudolph, J. L.; Yang, Frances Margaret; Kiely, D. K.; Inouye, S. K.

In: Neurology, Vol. 72, No. 18, 05.05.2009, p. 1570-1575.

Research output: Contribution to journalArticle

Fong, TG, Jones, RN, Shi, P, Marcantonio, ER, Yap, L, Rudolph, JL, Yang, FM, Kiely, DK & Inouye, SK 2009, 'Delirium accelerates cognitive decline in alzheimer disease', Neurology, vol. 72, no. 18, pp. 1570-1575. https://doi.org/10.1212/WNL.0b013e3181a4129a
Fong TG, Jones RN, Shi P, Marcantonio ER, Yap L, Rudolph JL et al. Delirium accelerates cognitive decline in alzheimer disease. Neurology. 2009 May 5;72(18):1570-1575. https://doi.org/10.1212/WNL.0b013e3181a4129a
Fong, T. G. ; Jones, R. N. ; Shi, P. ; Marcantonio, E. R. ; Yap, L. ; Rudolph, J. L. ; Yang, Frances Margaret ; Kiely, D. K. ; Inouye, S. K. / Delirium accelerates cognitive decline in alzheimer disease. In: Neurology. 2009 ; Vol. 72, No. 18. pp. 1570-1575.
@article{7f2aaff6af5744228a74193b13248ca4,
title = "Delirium accelerates cognitive decline in alzheimer disease",
abstract = "OBJECTIVE: To examine the impact of delirium on the trajectory of cognitive function in a cohort of patients with Alzheimer disease (AD). METHODS: A secondary analysis of data collected from a large prospective cohort, the Massachusetts Alzheimer's Disease Research Center's patient registry, examined cognitive performance over time in patients who developed (n = 72) or did not develop (n = 336) delirium during the course of their illnesses. Cognitive performance was measured by change in score on the Information-Memory- Concentration (IMC) subtest of the Blessed Dementia Rating Scale. Delirium was identified using a previously validated chart review method. Using linear mixed regression models, rates of cognitive change were calculated, controlling for age, sex, education, comorbid medical diagnoses, family history of dementia, dementia severity score, and duration of symptoms before diagnosis. RESULTS: A significant acceleration in the slope of cognitive decline occurs following an episode of delirium. Among patients who developed delirium, the average decline at baseline for performance on the IMC was 2.5 points per year, but after an episode of delirium there was further decline to an average of 4.9 points per year (p = 0.001). Across groups, the rate of change in IMC score occurred about three times faster in those who had delirium compared to those who did not. CONCLUSIONS: Delirium can accelerate the trajectory of cognitive decline in patients with Alzheimer disease (AD). The information from this study provides the foundation for future randomized intervention studies to determine whether prevention of delirium might ameliorate or delay cognitive decline in patients with AD.",
author = "Fong, {T. G.} and Jones, {R. N.} and P. Shi and Marcantonio, {E. R.} and L. Yap and Rudolph, {J. L.} and Yang, {Frances Margaret} and Kiely, {D. K.} and Inouye, {S. K.}",
year = "2009",
month = "5",
day = "5",
doi = "10.1212/WNL.0b013e3181a4129a",
language = "English (US)",
volume = "72",
pages = "1570--1575",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "18",

}

TY - JOUR

T1 - Delirium accelerates cognitive decline in alzheimer disease

AU - Fong, T. G.

AU - Jones, R. N.

AU - Shi, P.

AU - Marcantonio, E. R.

AU - Yap, L.

AU - Rudolph, J. L.

AU - Yang, Frances Margaret

AU - Kiely, D. K.

AU - Inouye, S. K.

PY - 2009/5/5

Y1 - 2009/5/5

N2 - OBJECTIVE: To examine the impact of delirium on the trajectory of cognitive function in a cohort of patients with Alzheimer disease (AD). METHODS: A secondary analysis of data collected from a large prospective cohort, the Massachusetts Alzheimer's Disease Research Center's patient registry, examined cognitive performance over time in patients who developed (n = 72) or did not develop (n = 336) delirium during the course of their illnesses. Cognitive performance was measured by change in score on the Information-Memory- Concentration (IMC) subtest of the Blessed Dementia Rating Scale. Delirium was identified using a previously validated chart review method. Using linear mixed regression models, rates of cognitive change were calculated, controlling for age, sex, education, comorbid medical diagnoses, family history of dementia, dementia severity score, and duration of symptoms before diagnosis. RESULTS: A significant acceleration in the slope of cognitive decline occurs following an episode of delirium. Among patients who developed delirium, the average decline at baseline for performance on the IMC was 2.5 points per year, but after an episode of delirium there was further decline to an average of 4.9 points per year (p = 0.001). Across groups, the rate of change in IMC score occurred about three times faster in those who had delirium compared to those who did not. CONCLUSIONS: Delirium can accelerate the trajectory of cognitive decline in patients with Alzheimer disease (AD). The information from this study provides the foundation for future randomized intervention studies to determine whether prevention of delirium might ameliorate or delay cognitive decline in patients with AD.

AB - OBJECTIVE: To examine the impact of delirium on the trajectory of cognitive function in a cohort of patients with Alzheimer disease (AD). METHODS: A secondary analysis of data collected from a large prospective cohort, the Massachusetts Alzheimer's Disease Research Center's patient registry, examined cognitive performance over time in patients who developed (n = 72) or did not develop (n = 336) delirium during the course of their illnesses. Cognitive performance was measured by change in score on the Information-Memory- Concentration (IMC) subtest of the Blessed Dementia Rating Scale. Delirium was identified using a previously validated chart review method. Using linear mixed regression models, rates of cognitive change were calculated, controlling for age, sex, education, comorbid medical diagnoses, family history of dementia, dementia severity score, and duration of symptoms before diagnosis. RESULTS: A significant acceleration in the slope of cognitive decline occurs following an episode of delirium. Among patients who developed delirium, the average decline at baseline for performance on the IMC was 2.5 points per year, but after an episode of delirium there was further decline to an average of 4.9 points per year (p = 0.001). Across groups, the rate of change in IMC score occurred about three times faster in those who had delirium compared to those who did not. CONCLUSIONS: Delirium can accelerate the trajectory of cognitive decline in patients with Alzheimer disease (AD). The information from this study provides the foundation for future randomized intervention studies to determine whether prevention of delirium might ameliorate or delay cognitive decline in patients with AD.

UR - http://www.scopus.com/inward/record.url?scp=67649389937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649389937&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3181a4129a

DO - 10.1212/WNL.0b013e3181a4129a

M3 - Article

C2 - 19414723

AN - SCOPUS:67649389937

VL - 72

SP - 1570

EP - 1575

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 18

ER -